L. Ekblad

发表

Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects

J. Hirvonen, S. Helin, M. Scheinin, 2019, Neuropsychopharmacology.

Four subgroups based on tau levels in Alzheimer’s disease observed in two independent cohorts

W. M. van der Flier, P. Scheltens, P. Visser, 2021, Alzheimer's Research & Therapy.

Insulin Resistance and the Brain–Novel Insights Combining Metabolic Research and Neuroscience

E. Rebelos, Laura L. Ekblad, L. Ekblad, 2022, Metabolites.

Brain Glucose Metabolism in Health, Obesity, and Cognitive Decline—Does Insulin Have Anything to Do with It? A Narrative Review

J. Rinne, P. Nuutila, E. Rebelos, 2021, Journal of clinical medicine.

The Obesity Risk SNP (rs17782313) near the MC4R Gene Is Not Associated with Brain Glucose Uptake during Insulin Clamp—A Study in Finns

L. Nummenmaa, J. Hannukainen, P. Nuutila, 2021, Journal of clinical medicine.

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.

Keith A. Johnson, D. Y. Lee, W. M. van der Flier, 2022, JAMA neurology.

Effects of age, BMI and sex on the glial cell marker TSPO — a multicentre [11C]PBR28 HRRT PET study

Yiyun Huang, K. Cosgrove, R. Carson, 2019, bioRxiv.

Midlife insulin resistance, APOE genotype, and late-life brain amyloid accumulation

M. Viitanen, A. Jula, S. Helin, 2018, Neurology.

Insulin resistance is associated with poorer verbal fluency performance in women

M. Viitanen, A. Jula, S. Ahtiluoto, 2015, Diabetologia.

White matter integrity and its association with amyloid-PET and serum NfL in healthy APOE4 homozygotes, heterozygotes and non-carries

S. Helin, K. Blennow, H. Zetterberg, 2023, medRxiv.

Insulin Resistance Predicts Cognitive Decline: An 11-Year Follow-up of a Nationally Representative Adult Population Sample

M. Viitanen, A. Jula, S. Ahtiluoto, 2017, Diabetes Care.

Head-to-head comparison of plasma p-tau181, p-tau231 and glial fibrillary acidic protein in clinically unimpaired elderly with three levels of APOE4-related risk for Alzheimer's disease

K. Blennow, S. Helin, J. Rinne, 2023, Neurobiology of Disease.

Midlife Insulin Resistance as a Predictor for Late-Life Cognitive Function and Cerebrovascular Lesions

M. Viitanen, A. Jula, J. Lötjönen, 2019, Journal of Alzheimer's disease : JAD.

Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly

K. Blennow, J. Lötjönen, S. Helin, 2024, Alzheimer's research & therapy.

ASIC-E4: Interplay of Beta-Amyloid, Synaptic Density and Neuroinflammation in Cognitively Normal Volunteers With Three Levels of Genetic Risk for Late-Onset Alzheimer's Disease – Study Protocol and Baseline Characteristics

K. Blennow, V. Oikonen, R. Parkkola, 2022, Frontiers in Neurology.

Insulin resistance and body mass index are associated with TSPO PET in cognitively unimpaired elderly

S. Helin, J. Rinne, J. Tuisku, 2023, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Midlife insulin resistance, APOE genotype, and change in late-life brain beta-amyloid accumulation – A 5-year follow-up [11C]PIB-PET study

A. Jula, S. Helin, J. Tuisku, 2023, Neurobiology of Disease.

Proteomic correlates of cortical thickness in cognitively normal individuals with normal and abnormal cerebrospinal fluid beta-amyloid1-42

P. Visser, B. Tijms, Laura L. Ekblad, 2021, Neurobiology of Aging.

Cognitively healthy APOE4/4 carriers show white matter impairment associated with serum NfL and amyloid-PET

K. Blennow, S. Helin, Elina Pietilä, 2024, Neurobiology of Disease.